Praxis Precision Medicines Inc
PRAX
NASDAQ
Biotechnology
$366.81
USD
-1.65 (-0.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $10.29B
Volume 262.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MDGL | Madrigal Pharmaceuticals Inc | $11.91B | - | +149.0% | - | |
SMMT | Summit Therapeutics Inc | $11.86B | - | - | - | |
HALO | Halozyme Therapeutics Inc | $11.55B | 27.93 | +41.1% | - | |
CYTK | Cytokinetics Inc | $10.36B | - | -21.1% | - | |
PRAX | Praxis Precision Medicines Inc | $10.25B | - | - | - | |
APGE | Apogee Therapeutics Inc | $10.18B | - | - | - | |
PTGX | Protagonist Therapeutics Inc | $9.93B | 119.77 | +34.8% | - | |
KRYS | Krystal Biotech Inc | $9.71B | 40.23 | +22.6% | - | |
SYRE | Spyre Therapeutics Inc | $9.29B | - | - | - | |
IONS | Ionis Pharmaceuticals Inc | $9.28B | - | -7.5% | - |
Top Peer by Growth
Madrigal Pharmaceuticals Inc
+149.0% YoY Revenue
Lowest P/E Ratio
Halozyme Therapeutics Inc
27.63x P/E
Best 1-Year Return
Praxis Precision Medicines Inc
+697.2% Return